State Street Corp Cor Medix Inc. Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Cor Medix Inc. stock. As of the latest transaction made, State Street Corp holds 1,601,648 shares of CRMD stock, worth $18.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,601,648

Previous 1,539,123 4.06%

Holding current value

$18.4 Million

Previous $9.48 Million 108.14%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.86 - $16.56 $366,396 - $1.04 Million	62,525 Added 4.06%	1,601,648 $19.7 Million
Q1 2025 May 15, 2025	BUY	$6.16 - $12.57 $529,606 - $1.08 Million	85,975 Added 5.92%	1,539,123 $9.48 Million
Q4 2024 Feb 14, 2025	BUY	$8.1 - $13.59 $1.84 Million - $3.09 Million	227,392 Added 18.55%	1,453,148 $11.8 Million
Q3 2024 Nov 14, 2024	BUY	$3.64 - $8.23 $37,142 - $83,978	10,204 Added 0.84%	1,225,756 $9.9 Million
Q2 2024 Aug 14, 2024	BUY	$4.08 - $6.39 $431,231 - $675,384	105,694 Added 9.52%	1,215,552 $5.26 Million
Q1 2024 May 15, 2024	BUY	$2.94 - $4.24 $107,968 - $155,709	36,724 Added 3.42%	1,109,858 $4.71 Million
Q4 2023 Feb 14, 2024	BUY	$3.0 - $4.01 $575,925 - $769,819	191,975 Added 21.79%	1,073,134 $4.03 Million
Q3 2023 Nov 14, 2023	BUY	$3.6 - $4.46 $244,220 - $302,561	67,839 Added 8.34%	881,159 $3.26 Million
Q2 2023 Aug 14, 2023	BUY	$3.94 - $5.8 $2.64 Million - $3.89 Million	669,991 Added 467.45%	813,320 $3.22 Million
Q4 2022 Feb 14, 2023	SELL	$2.81 - $4.45 $76,713 - $121,485	-27,300 Reduced 16.0%	143,329 $604,000
Q3 2022 Nov 15, 2022	SELL	$2.82 - $7.52 $63,010 - $168,026	-22,344 Reduced 11.58%	170,629 $483,000
Q2 2022 Aug 15, 2022	SELL	$2.73 - $5.61 $1.35 Million - $2.77 Million	-493,900 Reduced 71.91%	192,973 $776,000
Q1 2022 May 16, 2022	SELL	$3.83 - $6.24 $57,254 - $93,281	-14,949 Reduced 2.13%	686,873 $3.76 Million
Q4 2021 Feb 14, 2022	BUY	$4.47 - $5.56 $23,722 - $29,506	5,307 Added 0.76%	701,822 $3.19 Million
Q3 2021 Nov 15, 2021	BUY	$4.46 - $7.11 $293,740 - $468,271	65,861 Added 10.44%	696,515 $3.24 Million
Q2 2021 Aug 16, 2021	SELL	$6.05 - $10.09 $217,539 - $362,806	-35,957 Reduced 5.39%	630,654 $4.33 Million
Q1 2021 May 17, 2021	BUY	$6.84 - $17.58 $826,306 - $2.12 Million	120,805 Added 22.13%	666,611 $6.66 Million
Q4 2020 Feb 16, 2021	BUY	$5.0 - $9.15 $208,305 - $381,198	41,661 Added 8.26%	545,806 $4.06 Million
Q3 2020 Nov 10, 2020	BUY	$3.96 - $6.15 $102,647 - $159,414	25,921 Added 5.42%	504,145 $3.04 Million
Q2 2020 Aug 14, 2020	BUY	$3.08 - $6.56 $70,676 - $150,532	22,947 Added 5.04%	478,224 $3.01 Million
Q1 2020 May 11, 2020	BUY	$2.35 - $7.08 $1.07 Million - $3.22 Million	455,277 New	455,277 $1.63 Million

Others Institutions Holding CRMD

# of Institutions

182

Shares Held

32.5M

Call Options Held

867K

Put Options Held

561K

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $474M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Cor Medix Inc. Transaction History